|
|
||||||||
PHYSIOLOGICAL REVIEWS Vol. 78 No. 3 July 1998, pp. 583-686
Copyright ©1998 by the American Physiological Society
The Physiological Laboratory, Cambridge, United Kingdom
I. INTRODUCTION
A. Angiotensin-Induced Drinking Behavior
B. Renin-Angiotensin Systems
II. HYPOVOLEMIC THIRST AND SODIUM APPETITE
A. Causes of Hypovolemic Thirst
B. Detection of Hypovolemia and the Threshold of Response
C. Arousal of Sodium Appetite
D. Initial Evidence Suggesting Involvement of the Renal Renin-Angiotensin System in Drinking Caused by Hypovolemia
E. The Question of Whether Angiotensins Originating in Brain and Other Tissues Are Involved in Drinking Behavior
F. Comment
III. ANGIOTENSIN-INDUCED THIRST
A. Angiotensin-Induced Water Intake in Rat
B. Angiotensin-Induced Water Intake in Other Mammals
C. Angiotensin-Induced Water Intake in Birds, Reptiles, and Fish
D. Amphibians
E. Importance of Sodium
F. Comment
IV. ANGIOTENSIN-INDUCED SODIUM APPETITE
A. Angiotensin-Induced Sodium Intake
B. Angiotensin-Induced Sodium Appetite, a More Complex Response Than Angiotensin-Induced Thirst
C. Comment
V. EFFECTS OF ANGIOTENSIN ANALOGS AND ANTAGONISTS ON DRINKING
A. Angiotensin Structure-Activity and Drinking
B. Angiotensin Antagonists
C. Renin and Angiotensin II Precursors
D. Angiotensin-(1--7) Heptapeptide
E. Angiotensin-(2--8) Heptapeptide or Angiotensin III
F. Angiotensin-(3--8) Hexapeptide or Angiotensin IV and Shorter Chain Angiotensin Peptides
G. Comment
VI. CENTRAL NERVOUS SYSTEM AND ANGIOTENSIN-INDUCED DRINKING
A. C-fos Expression After Angiotensin
B. Circumventricular Organs
C. Anteroventral Third Ventricular Region and Lamina Terminalis
D. Organum Vasculosum of the Lamina Terminalis
E. Subfornical Organ
F. Amygdala
G. Brain Stem and Area Postrema
H. Comment
VII. ROLE OF ANGIOTENSIN PEPTIDES FORMED FROM PRECURSORS IN BRAIN IN DRINKING
A. Components and Distribution
B. Possible Functions
C. Role in Drinking
D. Comment
VIII. NEUROTRANSMITTERS AND ANGIOTENSIN-INDUCED DRINKING
A. Acetylcholine
B. Catecholamines
C. Serotonin
D. Excitatory and Inhibitory Amino Acids
E. Tachykinins and Bombesin-Like Peptides
F. Opioids
G. Endothelins
H. Natriuretic Peptides
I. Vasopressin
J. Oxytocin
K. Prostaglandins
L. Nitric Oxide
M. Other Neuroactive Substances
N. Comment
IX. DRUG-INDUCED HYPERRENINEMIA AND DRINKING
A.-Adrenergics
B. Furosemide
C. Angiotensin-Converting Enzyme Inhibitors
D. Histamine
E. Serotonin
F. 3,4-Methylenedioxymethamphetamine
G. Insulin
H. Comment
X. EXPERIMENTAL AND CLINICAL CAUSES OF RENIN-DEPENDENT DRINKING
A. Obstruction of the Inferior Vena Cava
B. Heart Failure
C. Hyperoncotic Dialysis
D. Sodium Appetite of Adrenal Insufficiency
E. Circulatory Shock
F. Experimental Renal Hypertension
G. Diseases of the Kidney and Hyperreninemia
H. Ureteric Ligation
I. Diabetes Insipidus and the Brattleboro Rat
J. Diabetes Mellitus
K. Comment
XI. CONCLUSIONS
REFERENCES
| |
ABSTRACT |
|---|
|
|
|---|
Fitzsimons, J. T. Angiotensin, Thirst, and Sodium Appetite. Physiol. Rev. 78: 583-686, 1998.
Angiotensin (ANG) II is a powerful and phylogenetically widespread stimulus to thirst and sodium appetite. When it is injected directly into sensitive areas of the brain, it causes an immediate increase in water intake followed by a slower increase in NaCl intake. Drinking is vigorous, highly motivated, and rapidly completed. The amounts of water taken within 15 min or so of injection can exceed what the animal would spontaneously drink in the course of its normal activities over 24 h. The increase in NaCl intake is slower in onset, more persistent, and affected by experience. Increases in circulating ANG II have similar effects on drinking, although these may be partly obscured by accompanying rises in blood pressure. The circumventricular organs, median preoptic nucleus, and tissue surrounding the anteroventral third ventricle in the lamina terminalis (AV3V region) provide the neuroanatomic focus for thirst, sodium appetite, and cardiovascular control, making extensive connections with the hypothalamus, limbic system, and brain stem. The AV3V region is well provided with angiotensinergic nerve endings and angiotensin AT1 receptors, the receptor type responsible for acute responses to ANG II, and it responds vigorously to the dipsogenic action of ANG II. The nucleus tractus solitarius and other structures in the brain stem form part of a negative-feedback system for blood volume control, responding to baroreceptor and volume receptor information from the circulation and sending ascending noradrenergic and other projections to the AV3V region. The subfornical organ, organum vasculosum of the lamina terminalis and area postrema contain ANG II-sensitive receptors that allow circulating ANG II to interact with central nervous structures involved in hypovolemic thirst and sodium appetite and blood pressure control. Angiotensin peptides generated inside the blood-brain barrier may act as conventional neurotransmitters or, in view of the many instances of anatomic separation between sites of production and receptors, they may act as paracrine agents at a distance from their point of release. An attractive speculation is that some are responsible for long-term changes in neuronal organization, especially of sodium appetite. Anatomic mismatches between sites of production and receptors are less evident in limbic and brain stem structures responsible for body fluid homeostasis and blood pressure control. Limbic structures are rich in other neuroactive peptides, some of which have powerful effects on drinking, and they and many of the classical nonpeptide neurotransmitters may interact with ANG II to augment or inhibit drinking behavior. Because ANG II immunoreactivity and binding are so widely distributed in the central nervous system, brain ANG II is unlikely to have a role as circumscribed as that of circulating ANG II. Angiotensin peptides generated from brain precursors may also be involved in functions that have little immediate effect on body fluid homeostasis and blood pressure control, such as cell differentiation, regeneration and remodeling, or learning and memory. Analysis of the mechanisms of increased drinking caused by drugs and experimental procedures that activate the renal renin-angiotensin system, and clinical conditions in which renal renin secretion is increased, have provided evidence that endogenously released renal renin can generate enough circulating ANG II to stimulate drinking. But it is also certain that other mechanisms of thirst and sodium appetite still operate when the effects of circulating ANG II are blocked or absent, although it is not known whether this is also true for angiotensin peptides formed in the brain. Whether ANG II should be regarded primarily as a hormone released in hypovolemia helping to defend the blood volume, a neurotransmitter or paracrine agent with a privileged role in the neural pathways for thirst and sodium appetite of all kinds, a neural organizer especially in sodium appetite, or all of these, remains uncertain. ANG II-induced drinking behavior serves as a model of how other complex behaviors involving neural and peptide inputs might be organized.
Angiotensin-induced drinking behavior is a remarkable phenomenon. I discuss it in detail and analyze the different circumstances in which angiotensin peptides may be involved in thirst and sodium appetite. There has been an enormous amount of work on these topics in the past 30 years, and it would be impracticable to survey all that has been published. What follows is therefore selective and very much what has interested me. I have tried to allow for personal bias by citing key review articles or chapters in books for certain aspects of the work described here. I have also given an extended list of monographs, multiauthor works, and conference proceedings devoted to thirst, sodium appetite, and renin-angiotensin systems. Thirst is a sensation aroused by a need for water, and relief from it is sought by drinking water. We infer from our own experience in similar circumstances that the dehydrated animal eagerly seeking water is also experiencing thirst. But lecturing, singing, eating a spicy meal, seeking pleasure from a refreshing drink of water on a hot day, or just habit may lead to increased consumption of water, although there may be no immediate need for it and no thirst in the strict sense of the word. Perhaps the appropriate term to use here is appetite for water. There are also circumstances in which animals continue to drink water or can be made to do so even though their needs for water have been met many times over. For example, rats infused with more water than they needed in the 24 h, by routes that bypassed the mouth and pharynx, continued to drink spontaneously about one-third or more of their preinfusion intake of water (184). It is important to be aware of circumstances such as these when assessing the results of experiments on drinking behavior. We reasonably assume that animals experience the same sensations as ourselves when they suffer the same deficits, but we should also recognize that animals, like ourselves, drink water for reasons other than to repair a water deficit; they have urges and preferences as well as needs that they seek to gratify. And although it is desirable that we restrict the word thirst to the sensation aroused by a lack of water, in general usage it incorporates both an idea of appetite for water as well as a drive toward relief of a need. We are often tempted by water as well as driven to assuage our thirst. Increased sodium appetite indicates a need for sodium, and relief will be sought by consuming salt or salty foods. But much more so than with thirst, experience of a previous occasion of sodium deficit and the satisfaction afforded by the taste of salt and consequent intake may so condition behavior that an appetite for repetition of this experience is quickly established. In other words, sodium intake is commonly driven by preference as well as need, and the subject gains satisfaction from it as well as relief. Cannon (89) wrote, "It is not to be supposed that the two motivating agencies A. Angiotensin-Induced Drinking Behavior
1. A model of a peptidergic control system
![]()
I. INTRODUCTION
Top
Next
References
the pang and the pleasure
are as separate as we have been regarding them for the purposes of analysis in the present discussion. They may be closely mingled; when relief from hunger or thirst is found, the appetite may simultaneously be satiated." Cannon was discussing hunger (the pang) and appetite (the pleasure) for food, but his remarks apply with equal force to hunger or appetite for sodium. In most circumstances of sodium need, sodium intake is undoubtedly driven by need, but there is also an element of preference: both the pang and the pleasure operate. These are the reasons why, like most workers in the field from Richter (479) onward, I have preferred to use the word sodium or salt appetite rather than sodium hunger, since appetite implies preference as well as need and it takes account of the powerful effects of learning on the response to a need. I have also preferred to use sodium instead of salt because salt can mean a nonsodium salt.
2. Reviews and books on angiotensin, thirst, and sodium appetite
Renin is dealt with in comprehensive detail in Robertson and Nicholls' (482) multiauthor treatise, The Renin-Angiotensin System. Many outstanding reviews have appeared over the years on various aspects of the renin-angiotensin system. These include "Angiotensin" (Page and Bumpus, Ref. 434), "Pharmacology of angiotensin" (Regoli et al., Ref. 468), "Renin-angiotensin system: biochemistry and mechanisms of action" (Peach, Ref. 440), "Renin 1978" (Peart, Ref. 441), "The pharmacologic alteration of renin release" (Keeton and Campbell, Ref. 303), "Actions of angiotensin II on the brain: mechanisms and physiologic role" (Reid, Ref. 469), and "Morphology, physiology, and molecular biology of renin secretion" (Hackenthal et al., Ref. 251). All aspects of angiotensin responsiveness in birds, including drinking behavior, are covered in a notable review "Central nervous angiotensin II responsiveness in birds" (Simon et al., Ref. 534). Brain renin and angiotensin are covered by the following excellent reviews: "The brain renin-angiotensin system: basic and functional considerations" (Ganten et al., Ref. 231), "Angiotensin" (Lind and Ganten, Ref. 342), "Regulatory role of brain angiotensins in the control of physiological and behavioral responses" (Wright and Harding, Ref. 674), "Brain and pituitary angiotensin" (Saavedra, Ref. 506), and "The renin-angiotensin system in the brain: an update 1993" (Bunnemann et al., Ref. 77). There are also valuable articles in the conference proceedings: Angiotensin and Blood Pressure Regulation (edited by Harding et al., Ref. 256). The rapidly moving field of angiotensin receptors is dealt with in "Angiotensin II receptor subtypes: characterization, signaling mechanisms, and possible physiological implications" (Bottari, de Gasparo, Steckelings, and Levens, Ref. 53), "Angiotensin II receptors and angiotensin II receptor antagonists" (Timmermans et al., Ref. 622), "Brain angiotensin receptor subtypes in the control of physiological and behavioral responses" (Wright and Harding, Ref. 675), "Receptor-mediated effects of angiotensin II on neurons" (Sumners et al., Ref. 580), "The angiotensin IV system: functional implications" (Wright et al., Ref. 677), "Brain angiotensin receptor subtypes AT1 , AT2 , and AT4 and their functions" (Wright and Harding, Ref. 676), and "Angiotensin receptors in the brain; their role in physiology and behaviour" (Mosimann et al., Ref. 406). A selection of monographs, reviews, multiauthor works, or conference proceedings on angiotensin-induced drinking behavior or more generally on thirst and sodium appetite with coverage of angiotensin-induced drinking follows. These are the works that I have most used, and the list is not exhaustive: "Thirst" (Fitzsimons, Ref. 182), The Neuropsychology of Thirst (edited by Epstein et al., Ref. 150), Control Mechanisms of Drinking (edited by Peters et al., Ref. 447), "Regulation of water intake" (Andersson, Ref. 9), The Physiology of Thirst and Sodium Appetite (Fitzsimons, Ref. 184), "Mécanismes de réglage de l'ingestion d'eau" (Peters, Ref. 446), "Angiotensin stimulation of the central nervous system" (Fitzsimons, Ref. 185), Thirst (Rolls and Rolls, Ref. 491), The Hunger for Salt: an Anthropological, Physiological and Medical Analysis (Denton, Ref. 122), Body Fluid Homeostasis (edited by Nicolaidis and Fitzsimons, Ref. 419), The Physiology of Thirst and Sodium Appetite (edited by de Caro et al., Ref. 114), Circumventricular Organs and Body Fluids (edited by Gross, Ref. 242), Thirst and Sodium Appetite: Physiological Basis (Grossman, Ref. 246), Neurobiology of Food and Fluid Intake (edited by Stricker, Ref. 565), Thirst: Physiological and Psychological Aspects (edited by Ramsay and Booth, Ref. 462), Sodium Hunger: the Search for a Salty Taste (Schulkin, Ref. 523), Angiotensin in Thirst and Hydromineral Balance (edited by Thornton, Ref. 605), "The neuroendocrinolgy of thirst and sodium appetite: visceral sensory signals and mechanisms of central integration" (Johnson and Thunhorst, Ref, 292). Finally, a source for most of the early work on thirst is A. V. Wolf's classical text Thirst: Physiology of the Urge to Drink and Problems of Water Lack published in 1958 (667).B. Renin-Angiotensin Systems
1. A brief look at the past
Renin is a major renal hormone, but the kidney is the source of other humoral factors that may influence drinking behavior, and, of course, the effects of excretion itself on the body fluids also affect drinking. Interest in the kidney as an organ of internal secretion goes back at least to the end of the last century, but awareness of a possible direct role in the control of drinking behavior is much more recent. Tigerstedt and Bergman in their classic paper of 1898 (623) showed that saline extracts of renal cortex caused prolonged rises in blood pressure when injected into anesthetized rabbits. Medullary extracts were inactive. The pressor activity of cortical extracts tolerated heating to 54-56°C very well, but it was destroyed by boiling and it was nondialyzable. Tigerstedt and Bergman (623) named the active substance renin and suggested that overproduction of renin might be a factor in increased vascular resistance and cardiac hypertrophy in certain renal diseases. They drew attention in the opening paragraph of their paper to Brown-Séquard's theory that various organs release substances that are not among the usual catabolites but are of decisive importance for the overall functions of the body. Brown-Séquard and d'Arsonval (66) had found that nephrectomized animals survived longer and developed fewer symptoms when injected with kidney extracts than noninjected animals. Tigerstedt and Bergman (623) produced solid experimental support for the idea that the kidney secretes substances with specific actions, in this case a pressor substance, but they did not speculate on the possible role of substances secreted by the kidney and other organs in regulating vascular tone. The idea that the kidney has endocrine functions did not attract a great deal of further interest until the early 1930s. Pickering (455), in a well-known text, High Blood Pressure, first published in 1955, commented on the curious 40-year gap in the history of renin following Tigerstedt and Bergman's discovery of a pressor substance in the kidney. During this period, there were few and inconclusive experiments on renin, although there was a continuing interest in the relation between disease of the kidney and hypertension. In 1934, Goldblatt et al. (234) published their pioneering experiments on the production of hypertension in the dog by restricting the blood supply to the kidneys. While recognizing that the rise in pressure might be caused by a pressor substance in the blood, Goldblatt et al. (234) did not at this stage discuss whether renin was this substance, and they did not refer to Tigerstedt and Bergman's paper. However, the possibility that pressor substances released from the ischemic kidney were responsible soon led to the reinvestigation and revival of interest in renin as the prime candidate. By 1938, when the existence of renin was becoming firmly established, there was a growing belief that renin was an important factor in renal hypertension. Subsequently, many problems have had to be overcome in trying to elucidate the extent of its involvement in other types of hypertension that are not the concern of this review. Meanwhile, much of the physiology of the renin-angiotensin system was being worked out. In the 1940s, the enzymic nature of renin was demonstrated by Braun-Menéndez et al. (57) and Page and Helmer (435). Renin was found to produce its effects by acting on a substrate in plasma to yield an active octapeptide now identified as angiotensin II. Skeggs et al. (546) isolated two angiotensins (called hypertensins) by incubating pig renin with horse serum and determined the amino acid sequences (337, 545). These papers were published in 1956. At about the same time, Elliott and Peart (145) isolated two forms of angiotensin by incubating rabbit renin with ox serum and established the sequence of the decapeptide.2. The present
Since these pioneering experiments, the components of the renin-angiotensin cascade have been identified and characterized (Fig. 1). It is undisputed that the kidney is a major organ of internal secretion, as stated more than a hundred years ago by Brown-Séquard and d'Arsonval (66), producing many other substances as well as renin that are secreted into blood, lymph, or tissue. The source of renal renin is the juxtaglomerular apparatus, consisting of renin-producing cells in the media of the afferent glomerular arterioles and extraglomerular mesangial cells lying between the glomerulus and distal tubule of the same nephron. At this point, the distal tubular cells are columnar and form the macula densa. Reduced renal arterial perfusion or sodium delivery to the macula densa, increased renal
1-adrenergic nerve stimulation, circulating catecholamines, prostaglandins, and prostacyclin all cause secretion of active renin, whereas ANG II, atrial natriuretic peptide (ANP), and vasopressin are inhibitory. Active renin is an acid (aspartyl) protease with narrow substrate specificity limited to one peptide bond in the angiotensinogen molecule (280). Renins from various species are monomeric glycoproteins (except mouse) with molecular weights ranging from 36,000 to 40,000.
|
Angiotensin II itself is evolutionarily stable. Only two variants have been described, [Ile5]ANG II in humans and many other mammals and [Val5]ANG II in cattle, sheep, and nonmammalian vertebrates (see Table 3, sect. V). Because the effects of these two variants on drinking behavior are the same, the abbreviation ANG II will be used for both. Angiotensin peptides have numerous autonomic, endocrine, and behavioral effects. Angiotensin II itself causes contraction and hypertrophy of vascular smooth muscle, activation of sympathetic nerves and release of adrenomedullary hormones, secretion of aldosterone, release of pituitary hormones, and sodium and water conservation through its effects on renal hemodynamics and tubular reabsorption. It is also an exceptionally powerful stimulus of drinking behavior, causing increases in both thirst and sodium appetite. There are other less well-defined effects of angiotensin peptides on cell growth, membrane function, protein synthesis, prostaglandin (PG) release, learning, and memory. The effect on drinking behavior is one of the most striking actions of any hormone on behavior, an action that ties in with the crucial role of angiotensin peptides in the control of blood pressure and blood volume.
|
Many other organs, notably the central nervous system, have been found to contain renin and other enzymes that can cause formation of angiotensin peptides independently of the kidney (171, 229) (see sect. VII). Angiotensin II may be formed independently of ACE by pathways involving kallikrein- or chymase-type serine proteases (15). Serine proteases may also activate prorenin and metabolize angiotensinogen directly to ANG II (86). Little is certain about the possible functions of extrarenal angiotensins, but it is believed that brain angiotensins are involved in cardiovascular and body fluid homeostasis and probably in other functions as well. The traditional view of sequential processing in a linear renin-angiotensin cascade, giving rise to ANG II as the single biologically significant ligand, is an oversimplification, since it does not fully account for all the possibilities of angiotensinogen processing. Among the other biologically active angiotensin peptides produced are the COOH-terminal deleted heptapeptide ANG-(1--7) and two NH2-terminal deleted peptides, the heptapeptide ANG-(2--8), or ANG III, and the hexapeptide ANG-(3--8), or ANG IV. There may be others. The angiotensin peptides and antagonists referred to in this review are discussed in detail in section V. Because systemic ANG-(1--7) lowers the blood pressure after a small initial pressor response (36), it is now possible to envisage circumstances in which the different angiotensin peptides could have opposing functions in blood pressure control (236), and this could conceivably be true for other physiological functions. The use of antagonists of the various stages of the renin-angiotensin cascade has been an invaluable method of investigating the physiology of angiotensin-dependent processes and is dealt with at length in this review. One recent development has been the introduction of receptor subtype selective antagonists in the functional analysis of thirst and sodium appetite. At least two receptor subtypes for angiotensin have been identified in mammal, subtype 1 or AT1 and subtype 2 or AT2 (580, 621, 622), based on their different affinities for structurally dissimilar angiotensin antagonists (see sect. VB). There is considerable heterogeneity within the AT1 and AT2 receptor subpopulations, and there are also additional receptor subtypes that do not fit with the standard definition of the two main subtypes and that may have a role to play in drinking behavior. Most known angiotensin functions are associated with AT1 receptors that are found throughout the body in all species, but it is possible that important functions may be associated with other receptors as discussed in section V. The AT1 receptor is coupled by a G protein, and ANG II produces its effects by increasing cytosolic free calcium. More recent still has been the introduction of antisense oligonucleotides to block angiotensin synthesis or receptors (450). The genetic aspects of renin-angiotensin systems are beginning to be elucidated, and the genes encoding the proteins and receptors of renin-angiotensin systems are being identified. Clearly, the potential of approaches such as the use of antisense oligonucleotides and gene-knockout animal models is enormous, although few results are yet available. Work on renin-angiotensin systems has proliferated to a remarkable degree, but in every aspect of the physiology of these fascinating systems, there remain major uncertainties.
| |
II. HYPOVOLEMIC THIRST AND SODIUM APPETITE |
|---|
|
|
|---|
Cellular dehydration and hypovolemia are the two principal causes of deficit-induced drinking. Loss of cell water is detected by osmoreceptors (and possibly sodium-sensitive receptors) located in the hypothalamus and elsewhere that share in the cellular dehydration and give rise to thirst. There is long-standing evidence on monitoring of extracellular fluid volume by stretch receptors in the walls of the heart and vasculature (232, 547). Hypovolemia is detected by these receptors which cause a delayed increase in sodium appetite as well as thirst. It is in drinking behavior induced by hypovolemia that renin-angiotensin systems seem to be most involved. Circulating ANG II derived from renal renin contributes to hypovolemic thirst. It also plays a role in increased sodium appetite, acting with the mineralocorticoids and other hormones. The part played by ANG II formed locally in the brain in these behaviors is uncertain, but in the rat, it may be more important in sodium appetite than in thirst. Other angiotensin peptides formed in the periphery or brain may contribute, but information is lacking. The circumstance in which hypovolemia leads to increased intakes of water and NaCl, some of the methods used to elicit these behaviors, and early evidence implicating renal renin are considered here.
A. Causes of Hypovolemic Thirst
Experimental procedures that have been used to arouse hypovolemic thirst include bleeding, inducing sodium deficiency (371), causing sequestration of extracellular fluid by intraperitoneal (175) or subcutaneous injection (560, 567) of hyperoncotic colloid, and interfering with venous return to the heart by obstructing the inferior vena cava (176, 178, 197, 614). Among clinical causes are severe diarrhea and vomiting, some forms of renal disease, congestive heart failure, and circulatory shock. Many of the experimental and clinical causes are considered in section X. Hypovolemia leads to an increase in circulating ANG II, and this contributes to drinking, although it is not exclusively responsible for the overall drinking response. On the other hand, even in the absence of any other stimulus, thirst can be aroused by injecting ANG II or causing it to be formed by drugs or surgical procedures. Because there is no additional renal renin release in cellular dehydration, circulating ANG II does not contribute to the thirst aroused, although angiotensin of cerebral origin may (see sect. VII). In mixed cellular and extracellular dehydration, ANG II like any other thirst stimulus adds its effect to the overall drinking response. As for spontaneous day-to-day drinking, here water intake is usually in excess of need, and much of the evidence suggests that drinking is determined by habit, showing the characteristics of a nyctohemeral rhythm entrained with feeding, with no fluid deficit or hormonal signal involved (184). However, it has also been suggested that release of histamine and transient hypovolemia associated with feeding may cause release of enough renal renin to stimulate drinking.
B. Detection of Hypovolemia and the Threshold of Response
Hypovolemia is detected by vascular stretch receptors in various parts of the circulation and possibly by other types of receptor as well (197, 232, 252, 292, 522). Unloading of cardiopulmonary and arterial stretch receptors as venous return and cardiac output drop, pulse pressure narrows, and mean arterial pressure falls, causes a number of compensatory responses, including increased sympathetic activation; decreased vagal tone; increased secretion of renin, aldosterone, ACTH, and vasopressin; and increased drinking. Reflex circulatory adjustments to loss of volume are rapid; renal conservation of water and electrolytes and replacement of the deficits of water and sodium by intake mechanisms are slower responses that depend on both neural and hormonal mechanisms. A deficit in plasma volume of ~8-10% (or this degree of underfilling in critical receptor regions in the heart and blood vessels) causes significant drinking, a threshold that is considerably higher than the deficit of 1 or 2% of cellular water needed to arouse osmotic thirst.
It seems possible that the hypovolemic threshold is higher than the osmotic because the range of blood flow rates required in different activities is so extended and the scope for changes in the distribution of cardiac output and the partitioning of fluid across the capillary wall so great that it is necessary to avoid the controls of extracellular volume being constantly triggered by smaller changes in plasma volume. The ample reserve of fluid in the interstitial fluid compartment acts as a buffer for plasma volume and can be mobilized through operation of the Starling capillary filtration/reabsorption system should the need to correct hypovolemia arise. It would be inappropriate if the circulatory adjustments accompanying different levels of bodily activity were to arouse thirst because of what turned out to be temporary understimulation of vascular stretch receptors, which ended as soon as the activity diminished and circulatory function returned to the resting state. It would make little sense were hypovolemic thirst mechanisms to keep switching on and off in this way because of transient shifts of blood between vascular beds. But once the loss of circulating volume becomes significant and persistent, drinking under the control of hypovolemic thirst is as vigorous as that caused by equivalent cell dehydration, and the amounts of water drunk may be greater than after cellular dehydration of similar magnitude. The requirements of the cellular fluid compartment are different; in contrast to the variable volume demands of the circulation, stability of cellular water content is a necessary condition for normal cell function.
We can only speculate on the mechanisms that are responsible for the long-term precision of blood volume control. This control, which allows for large short-term variations in the distribution of blood and the partitioning of fluid between the plasma and interstitial compartments depending on circulatory needs, implies the accurate monitoring of volume in certain strategic regions of the circulation, at least for part of the time, perhaps integrated over the long-term during periods of rest.
Neural and hormonal effector mechanisms vary the intake, distribution, and excretion of fluid and electrolytes in accordance with long-term needs. The immediate increase in water intake is caused by altered neural inputs from the vasculature reinforced by increases in circulating ANG II. Circulating ANG II contributes directly to the overall drinking response by stimulating structures in the central nervous system and, if the hypovolemia is severe, it is also important in maintaining the blood pressure and therefore the behavioral competence of the animal. However, it is not essential in hypovolemic thirst that can occur in the absence of circulating ANG II.
C. Arousal of Sodium Appetite
An increase in sodium appetite is the second behavioral response to hypovolemia. Many mammals in sodium deficit seek and ingest salt, driven to do so by increased sodium appetite (122, 498, 523), an innate behavior that serves sodium homeostasis (148). Sodium appetite is also expressed in many birds, including the pigeon. Animals seek and ingest what they like as well as what they need, and much sodium intake is preference driven; for ourselves, table salt is a common condiment, and sodium-replete rats readily accept and drink large quantities of isotonic NaCl, the saline concentration they prefer. Sodium is normally a major urinary constituent and represents the excess of intake over the amounts needed by the body. It is important in the investigation of need-driven sodium appetite to offer concentrations of sodium solutions that the sodium-replete animals normally avoid. Under these conditions, we can be reasonably sure that any NaCl intake is need driven. Sodium appetite is well developed in inland-dwelling herbivores including some primates, particularly during pregnancy and lactation when calls on fluid and electrolyte reserves of the body are greatest, or when sodium deficiency develops as a result of, for example, intestinal infection. Herbivores in the wild may travel long distances to places where salt is to be found, and this is presumably why their predators also tend to congregate at these places. But omnivores, including humans, and carnivores when they are unable to satisfy their sodium needs from their prey, show increased sodium appetite when sodium deficient.
Inducing sodium deficiency by placing the subject on a low-sodium regime is the simplest way to generate an appetite, and of course, here ANG II levels increase. The combination of dietary restriction and enforced sweating was used by McCance (371) in his classical experiments on himself and colleagues, published in 1936, on the effects of inducing sodium chloride deficiency and, although the study of sodium appetite was not the primary purpose of this experiment, the subjects made some interesting observations on alterations in their sense of flavor and taste. In a more recent study, experimental sodium deficiency in 10 human subjects caused increased preference for salty foods (32). More active procedures to make animals sodium deficient, which may be combined with dietary sodium restriction, are treatment with furosemide or other natriuretic drugs (see sect. IXB); peritoneal dialysis with isosmotic glucose; unilateral fistulation of the parotid salivary gland in sheep, calf, and goat (122); and adrenalectomy (see sect. XD). The methods used to arouse hypovolemic thirst also cause increased sodium appetite, and to these may be added subcutaneous injection of buffered Formalin, which is an effective natriorexigenic stimulus (669).
Sodium appetite can also be induced in the absence of need for sodium by administration of the hormones of sodium deficiency, the mineralocorticoids and ANG II, which are normally secreted in extra amounts in the circumstances just mentioned. But to these should be added the hormones of pregnancy and lactation and the stress hormones of the hypothalamo-pituitary-adrenocortical axis, corticotrophin releasing hormone (CRH), ACTH, and glucocorticoids (122, 597), although these are of varying effectiveness and there are species differences in the effects produced. Angiotensin II-induced sodium appetite is considered in detail in section IV, and the reproductive hormones are considered in sections IIIA4 and IVA3.
Increased sodium appetite caused by mineralocorticoids has been abundantly studied and verified since Richter's discovery of the phenomenon more than 50 years ago (122). A U-shaped function describes the effects of systemic administration of mineralocorticoid on sodium appetite; replacement doses of deoxycorticosterone acetate (DOCA) reverse the increased NaCl intake that follows adrenalectomy, whereas larger than replacement doses of DOCA or aldosterone stimulate NaCl intake in intact and adrenalectomized rats despite the accompanying sodium retention and suppression of renal renin secretion (56, 221, 475, 478, 479, 668). Arousal of sodium appetite depends on central actions of mineralocorticoids. Receptor binding studies have shown that there are two receptor subtypes for corticosteroids, mineralocorticoid (type I or MR), and glucocorticoid (type II or GR). Both are present in rat brain, and their regional distribution is similar. The highest uptakes of aldosterone and corticosterone are in the hippocampus, septum, and amygdala (402), and there is a brief report that bilateral adrenal steroid implants in the amygdala caused an increase in intake of NaCl but not water (472). Central nervous structures involved in increased sodium appetite are discussed in section VI.
Sodium appetite can be aroused in rats by inducing the syndrome of apparent mineralocorticoid excess (AME) using the active component of licorice, glycyrrhizic acid, or its hydrolytic product, 18
-glycyrrhetinic acid (105, 106). The pattern of increased drinking produced resembles that which occurs after administration of excessive amounts of mineralocorticoid, but plasma corticosteroid levels are not increased. Apparent mineralocorticoid excess has been identified as a cause of human hypertension (529). The clinical picture is similar to that produced by excess mineralocorticoids, with sodium retention, hypertension, potassium loss, and inhibition of the renin-angiotensin system. In type I AME, inactivation of glucocorticoids is impaired because the enzyme 11
-hydroxysteroid dehydrogenase (11
-OHSD), which oxidises cortisol to cortisone, is congenitally deficient or has been blocked by licorice (557). Type II AME is secondary to a deficiency in the A-ring reduction metabolic pathway. In rats, licorice prevents oxidation of corticosterone, the glucocorticoid in rodents, to 11-dehydrocorticosterone. Failure to inactivate glucocorticoids allows the mineralocorticoid receptors, whose affinities for glucocorticoids and mineralocorticoids in vitro are the same (402), to be powerfully stimulated by the large amounts, relative to aldosterone, of glucocorticoid present. Mineralocorticoid receptors, including those in brain (323), are normally protected from stimulation by glucocorticoids by this enzyme. Licorice inhibits 11
-OHSD activity in kidney and other tissues, exposing the mineralocorticoid receptors to glucocorticoid stimulation, but the 11-oxoreductase activity of liver is mainly unaffected, ensuring reconversion of inactive 11-ketosteroid to active glucocorticoid (401). Glycyrrhizic acid-induced increases in sodium appetite were abolished by adrenalectomy but could be restored by administration of cortisol or corticosterone but not by replacement dosage of DOCA (107). Increased sodium appetite in AME suggests that 11
-OHSD inactivation of glucocorticoid also operates in those parts of the brain responsible for mineralocorticoid-induced appetite.
The stimulating effect of DOCA is much smaller in rabbit and sheep, and aldosterone seems ineffective in these species (122). Dogs, hamsters, and gerbils also fail to show significant natriorexigenic responses to mineralocorticoids (498). On the other hand, it has been shown that several adrenal steroids in slow-release pellet form, of which deoxycorticosterone (DOC) was the most potent, evoked sodium appetite in BALB/c mice (45), although it was stated earlier that mice do not show a natriorexigenic response to mineralocorticoids (498, 499). The pigeon develops an increase in sodium appetite in response to subcutaneous DOCA (151). Glucocorticoids can generate sodium appetite in rabbit and sheep but in rat only when accompanied by mineralocorticoid (668). Adrenocorticotrophic hormone (Synacthen) stimulates sodium appetite in rabbit, rat (659), and sheep. In rabbit, the effect is mediated partly by the adrenal cortex, but there is also an extra-adrenal effect, since ACTH has some action in adrenalectomized animals, presumably by acting directly on the brain (122). Mineralocorticoid-induced sodium appetite is a primary natriorexigenic effect on brain; it is independent of and unaffected by the developing "escape" from mineralocorticoid action on the kidney. Corticosteroid therapy, or excessive mineralocorticoid secretion whether accompanied by increases or decreases in circulating ANG II, could contribute to inappropriate or excessive sodium intake in human. Continuing sodium intake in the face of sodium retention indicates that the intake is not homeostatically determined.
Mineralocorticoid treatment, or induction of AME, also causes increased water intake, which is usually regarded as being exclusively secondary to NaCl intake, but some increased intake also occurs when water only is available to drink in dog (164, 461) and rat on a high salt (475, 479) or normal (unpublished data) diet. Furthermore, the relation between water intake and NaCl intake is not always close; in mouse, DOC stimulated NaCl intake but had no effect on water intake, whereas the combination of DOC with other corticosteroids, and especially with ACTH, caused increased water intake as well as NaCl (45). Apart from the osmotic effect of the NaCl intake, increased water intake may be the result of mineralocorticoid-induced potassium depletion giving rise to cellular dehydration and failure of renal concentrating ability. Potassium deficiency has long been recognized as a cause of a diabetes insipidus-like syndrome with polydipsia and vasopressin-resistant polyuria both in animals and in humans. The stimulating effect of potassium depletion on water intake may be primary; the polyuria of hypokalemic subjects is often in excess of the urine volume required by their concentrating defect (39).
Increased sodium appetite is an essential and appropriate defense mechanism against sodium deficiency, but other mineral deficiencies may also cause increased NaCl intake. These are circumstances where the relation between sodium appetite and sodium need and/or its hormonal accompaniments appear to be completely absent. In addition to the polydipsia/polyuria syndrome already mentioned, potassium depletion in rat caused increased intake of NaCl as well as KCl (122). Rats also show increased sodium appetite in response to calcium depletion even in the absence of sodium loss or increases in the hormones of sodium homeostasis. The appetite is not related to plasma calcium levels, the hormones controlling calcium, or the renin-angiotensin-aldosterone system, and at present it is unexplained (627, 628).
Because ANG II and mineralocorticoids are central in the body's defenses against sodium loss and consequent hypovolemia, much of the experimental effort to try and elucidate the physiological basis of sodium appetite has been devoted to these hormones. One approach to investigate possible participation of renal renin in sodium appetite has been to lower plasma levels of renin and ANG II by bilateral nephrectomy, or to prevent the effects of renin secretion with appropriate renin-angiotensin system antagonists (see sect. V). Another approach has been to try to stimulate or restore sodium appetite by elevating plasma ANG II levels directly or by administering renin, or by stimulating renal renin secretion pharmacologically or surgically. These approaches complement studies on the possible role of cerebral renin in sodium appetite and its relation, if any, to renal renin; they are essentially those used to assess the renin contribution to thirst.
D. Initial Evidence Suggesting Involvement of the Renal Renin-Angiotensin System in Drinking Caused by Hypovolemia
I proposed that the renal renin-angiotensin system has a direct and physiological role in certain types of drinking behavior as a result of certain findings on caval obstruction as a stimulus to drinking in the rat (176, 178). The procedure of caval obstruction was devised as a method of mimicking the circulatory effects of severe hypovolemia. Within 30 min to 1 h after constriction of the abdominal inferior vena cava just above the renal veins, there was an increase in water intake followed much later by an increase in sodium intake; there was also a marked fall in urine flow and electrolyte excretion so that for a time the animal gained weight as it retained fluid. Because this stimulus to thirst was found to be less effective in the nephrectomized rat than in the intact rat, it seemed that renin or some other renal factor released as a result of the reduced venous return to the heart could have been partly responsible for the increased drinking. Making the rat anuric by bilateral ureteric ligation, a procedure which preserves the endocrine function of the kidney, did not prevent caval obstruction-induced drinking. Experimental support for the theory of renal renin involvement in this behavior came with the finding that saline extracts of the renal cortex of rat caused increased drinking especially in nephrectomized rats. The properties of the rat renal extract were found to be similar to those of renin and purified commercial pig renin caused a dose-dependent increase in drinking (178).
The idea that the kidney might contribute to thirst, although not through renin secretion, was proposed by Linazasoro et al. (341). They suggested that when the supply of water to the body is lacking, the kidney liberates a thirst factor that helps the body to resist dehydration. They found that in bilaterally nephrectomized rats that were allowed free access to water, the loss of body weight and fall in water intake that usually occur could be prevented by injecting an extract of pig kidney. Because renin apparently did not have these effects, Jiménez-Díaz et al. (288) concluded that the renal thirst factor is not renin. However, there were already clues that the renal thirst factor might indeed be renin. In a series of experiments on accelerated hypertensive disease in nephrectomized dogs (368) and rats (367), Masson and co-workers found that the syndrome was intensified by renin, which stimulated water intake. But they considered that increased drinking was secondary to hypovolemia consequent on increased capillary transudation and they stated that ". . . thirst induced by renin in nephrectomized rats is not the result of primary stimulation of thirst centers . . ." (367). Asscher and Anson (17) came to a similar conclusion, finding that renal extracts stimulated water intake in nephrectomized rats, but attributing this to hypovolemia caused by leakage of fluid into the tissues.
Because the caval obstruction experiments described above suggested that there are occasions when endogenously released renin as opposed to injected renin or renal extracts contributes to thirst, it seemed likely that renin acted by more physiological mechanisms than by causing or exacerbating hypovolemia. The question now arose whether, as for other effects of renin, increased drinking in response to caval obstruction was mediated by ANG II (178). This proved to be the case. It was found that ANG II caused increased drinking when infused intravenously into water-replete rats at doses below those which produced marked changes in hematocrit value and that it restored the nephrectomized rat's reduced water intake in response to caval obstruction near to that of a normal rat's response (200). In an investigation of norepinephrine-induced eating in rat, it had been observed that intrahypothalamic injection of ANG II caused drinking (51). It was now shown that injection of small amounts of ANG II into the anterior hypothalamus and preoptic region caused dose-dependent increases in water intake in the water-replete rat (149), suggesting that increased circulating ANG II caused drinking by acting on accessible structures in the central nervous system. Shortly after these early experiments on ANG II-induced water intake, intracranial ANG II was also shown to cause increased NaCl intake (72, 96).
E. The Question of Whether Angiotensins Originating in Brain and Other Tissues Are Involved in Drinking Behavior
The possible involvement of angiotensin peptides generated in the central nervous system in thirst and sodium appetite raises complicated issues that have yet to be resolved. These are discussed at length in section VII. There is evidence that central angiotensinergic pathways participate in hypovolemic drinking behavior, especially in NaCl intake. There is also evidence that they may be involved in the thirst of cellular dehydration. However, the ways and circumstances in which angiotensin peptides generated in situ in the brain might perform these functions, and the relation between angiotensins of central and peripheral origin are generally unknown.
Reninlike enzymes and other elements essential for the generation of angiotensin peptides are present in many other tissues as well as in brain and kidney. Ovarian and uterine renin-angiotensin systems perhaps could be involved in the heightened responsiveness of females to some dipsogenic stimuli (see sect. IIIA4) and to the increased intakes of water and NaCl during pregnancy and lactation. However, these possibilities have not been explored, and there are other factors that could be more important. Another tissue renin difference between the sexes is the exceptionally high content of salivary renin in male mice compared with female animals, but again, the physiological significance of this is unknown.
F. Comment
Hypovolemia is a more immediate threat to life than cellular dehydration so that mechanisms for the preservation and restoration of circulatory volume are vital for survival. The temporary respite afforded by the immediate reflex responses of the heart and blood vessels to loss of blood is rapidly consolidated by mobilization of interstitial fluid and by increased water intake followed by increased sodium intake, leading to restoration of circulating volume. The threshold blood loss for arousing hypovolemic thirst is ~8-10% compared with a threshold of 1-2% loss of cell water for osmotic thirst. The higher threshold for hypovolemic thirst reflects the huge range of blood flows required to match the variations in metabolic demands by the tissues with the general circulatory adjustments that these entail. The large volume of interstitial fluid acts as a buffer that can be mobilized to maintain the circulation as the need arises. When hypovolemia becomes persistent and a threat to survival, drinking is as vigorous as that caused by equivalent cellular dehydration. The role of increased renal renin secretion in hypovolemia is to reinforce the hemodynamic, renal, dipsogenic, and natriorexigenic responses to loss of circulating volume, especially when the fluid deficit is large and developing rapidly. Angiotensin peptides may also be generated in brain and elsewhere and could play a part in the increased thirst and sodium appetite of hypovolemia and perhaps in the altered fluid needs of reproduction, but the position is much less certain than it is for renal renin. Even in the case of renal renin, increased secretion is not essential for dipsogenic or natriorexigenic responses to hypovolemia, and it is not easy to measure its contribution. The rest of this review is devoted to detailed consideration of the physiological mechanisms and significance of thirst and sodium appetite induced by angiotensin peptides.
| |
III. ANGIOTENSIN-INDUCED THIRST |
|---|
|
|
|---|
One of the most striking stimulatory effects of any substance on any motivated behavior is the vigorous, short-latency burst of drinking that follows injection of ANG II into sensitive structures in the brain. The initial increase in water intake is followed by a developing increase in NaCl intake (see sect. IV). Systemic injection of ANG II also causes water-replete animals to start drinking, although the response is less predictable than after intracranial administration. Responsiveness to the dipsogenic effect of ANG II is present in all vertebrate groups examined (Table 1), including certain euryhaline bony fish, but excluding amphibians and elasmobranch fish. Renin and some other components of the renin-angiotensin cascade given by intracranial or systemic injection also cause increased drinking.
|
A. Angiotensin-Induced Water Intake in Rat
The greater part of experimental work on ANG II-induced drinking has been carried out on the laboratory rat. Most rat strains respond vigorously to the dipsogenic and natriorexigenic effects of ANG II.
1. Intracranial administration
The effect of ANG II on drinking is most obvious after intracranial administration. Angiotensin II-sensitive neurons for drinking, identified electrophysiologically, are present in the ventral lamina terminalis, certain of the circumventricular organs (CVOs), and limbic structures; these regions contain immunoreactive neurons and binding sites for ANG II. The detailed neuroanatomy of ANG II-induced drinking is dealt with in section VI. When ANG II is administered by intracranial injection through a permanently connected remote injection system so that the rat does not have to be disturbed by handling during the injection, the animal stops whatever it is doing, goes to the source of water, and starts to drink, usually <1 min after injection, and within 10-15 min will have consumed significant amounts of water (149, 527, 537). To the onlooker, the behavior appears entirely normal and indistinguishable from that produced by other potent thirst-inducing stimuli. Increased water intake precedes any significant increase in urine flow. For most purposes, it makes little difference whether ANG II is introduced by bolus injection or by slow infusion, directly into brain parenchyma or into cerebrospinal fluid (CSF), but drinking in response to bilateral injections of ANG II into the preoptic area (POA) was more robust and occurred at lower doses than to unilateral injections (476). Obviously, there will be differences in the tissue affected and the concentration of hormone reaching the particular tissue that may need to be taken into account when comparing dose-response relations or apparently contradictory results from different laboratories. Drinking proceeds with few interruptions and is dose dependent in the femtomole to nanomole range of ANG II; typically, doses in the range of 1-100 pmol (1-100 ng) in an injection volume of 1 µl are used. The threshold dose for the water-replete rat is ~0.1-1.0 fmol injected into the SFO (Fig. 2) or OVLT, two of the most sensitive structures to the dipsogenic action of ANG II (see sect. VI). The response is mediated by AT1 receptors (see sect. V). The quantities of water drunk are large. A male Wistar rat will drink ~10-15 ml water, after a latency measured in seconds, within 10-15 min of injecting 10 pmol ANG II into the anterior third ventricle. If the rat is prevented from drinking, it remains thirsty for up to ~90 min after this dose, although the amounts drunk when access is finally allowed decline with time (488). Even after the largest doses, drinking is largely completed within ~15 min. After larger doses of ANG II, the amounts of water consumed may exceed the amounts that the animal would drink in 24 h in the course of its normal day-to-day activities. Despite the immediate intake of water after intracranial ANG II, overnight intake is well-maintained. Continuous intracranial infusions of ANG II elicit even higher intakes than these; individual rats infused with ANG II at rates of 10 pmol/h may have 24-h fluid intakes that exceed their body weights.
|
Drinking behavior induced by quite moderate amounts of ANG II seems highly motivated. After 50 pmol ANG II injected into the lateral POA, rats pressed a lever as many as 64 times for a single reward of 0.1 ml water; the animals worked as hard for water as when they had been deprived of water for 24 h (489). After ANG II, a hungry rat stops eating, a curious rat stops exploring, a somnolent rat bestirs itself, and in each case the animal drinks after a short latency. A 10-ng dose of ANG II injected into the lateral POA induced drinking and suppressed feeding in 24-h food-deprived rats, but the suppression of feeding was completely prevented by a 15-ml intragastric preload of water or 0.9% NaCl, although drinking was only partly reduced and less so after 0.9% NaCl than after water (490). Systemic administration is dealt with later in this section, but it may be noted here that subcutaneous injection of ANG II caused rats to reduce their voluntary consumption of alcohol and drink water instead (247). It was suggested that ANG II might serve as a satiety signal in alcohol drinking. Intracranial ANG II or renin (see sect. VC) also increased the amounts of water drunk in response to intraperitoneal hypertonic NaCl, a cellular dehydration stimulus to thirst, or to intraperitoneal hyperoncotic polyethylene glycol, a hypovolemic stimulus to thirst (180). Drinking in response to intracranial injection of ANG II or renin can be elicited in bilaterally adrenalectomized or hypophysectomized rats (22), or in bilaterally nephrectomized rats (20). It is therefore a primary effect, not dependent on pituitary or adrenal hormones and not the consequence of increased urinary fluid loss. However, rats pretreated with dexamethasone 3-6 h previously drank more water in response to lateral ventricular (or intraperitoneal) injection of ANG II, although ANG II binding in the brain was unaffected by dexamethasone (227). In intact rats, intracranial injection of ANG II causes a rise in blood pressure mainly attributable to increased sympathetic nerve activity, but also to vasopressin release and resetting of the baroreceptor reflex (185, 449, 527, 553). The pressor and dipsogenic effects are separable in onset and duration. Angiotensin II infused into the lateral cerebral ventricle at 6 µg/h for 7 days led to transient dipsogenic and natriuretic responses but a sustained rise in blood pressure (130). The acute pressor response may attenuate intracranial ANG II-induced drinking. In rats in which endogenous ANG II formation was prevented by ACE blockade (see sect. IXC), the dipsogenic effect of an infusion of ANG II into the lateral ventricle was enhanced by simultaneous reduction in arterial blood pressure with intravenous minoxidil despite the increased fluid and electrolyte retention caused by the hypotension (617). The modulatory effect of alterations in arterial blood pressure on intracranial ANG II-induced drinking can occur in the absence of sinoaortic baroreceptor input. In ACE-blockaded rats, water intake was found to be inversely related to changes in arterial pressure caused by intravenous phenylephrine or minoxidil (620). This relation was still present after denervation but, as the authors pointed out, the failure of sinoaortic denervation to eliminate the modulatory effect of changes in blood pressure on ANG II-induced drinking occurred in the presence of the greater changes in mean arterial pressure produced by phenylephrine or minidoxil in denervated rats, i.e., after sinoaortic denervation drinking responses may have became partly refractory to the modulatory effects of changes in arterial pressure. This could mean that loss of baroreceptor function was having some effect. Clearly, volume receptor information from the vagally innervated atrial and cardiopulmonary receptors not affected by the sinoaortic denervation could have continued to modify drinking behavior. Pressure inhibition of drinking is further discussed next and in section IIIB2.
2. Systemic administration
An increase in drinking can also be produced by systemic administration of ANG II or its precursors, or by causing release of renin from the kidney by pharmacological or surgical means (see sects. IX and X). Although it is difficult to make direct comparisons because the techniques of administration are so different, the conditions required for eliciting drinking in response to systemic ANG II are more exacting than those for intracranial administration. With the use of appropriate doses to obtain maximal responses by the two routes, drinking responses caused by intravenous infusion are generally smaller than those following intracranial administration. In contrast to the robust drinking response that is almost invariably obtained with intracranial ANG II, there are well-documented cases in the literature where systemic ANG II has failed to cause drinking. Angiotension II is usually given by continuous intravenous infusion to unrestrained animals using an external infusion system (0.05-3.0 µg·kg
1·min
1; Ref. 200) or an implanted osmotic minipump. Subcutaneous (up to 500 µg; Ref. 291) or intraperitoneal (5-30 µg/100 g; Ref. 312) administration has also been used, but large doses of ANG II must be given. Intravenous ANG II was an effective stimulus to drinking on its own in water-replete rats, producing dose-dependent increases in water intake, the increases being greater in nephrectomized animals; combined with hypertonic NaCl, it caused a nephrectomized rat to drink and retain more water than after NaCl alone (200). The responsiveness of nephrectomized rats indicates that drinking was not secondary to increased urinary losses, although these may well have partly accounted for increased drinking after larger infusion rates in intact animals. As well as being the source of renal renin, the kidney is an important pathway of elimination of prorenin, renin, and angiotensins (556), and this must be one of the factors accounting for the enhanced responsiveness of nephrectomized rats compared with intact animals. The increases were not mediated by increased adrenal secretion because acutely adrenalectomized nephrectomized rats drank similar amounts of water as nephrectomized rats in response to intravenous ANG II, but dexamethasone given 3-6 h previously does cause extra drinking in response to intraperitoneal (or intracranial) ANG II (227). In the longer term after adrenalectomy, ANG II levels may decline (see sect. XD), resulting in upregulation of receptors that could lead to increased drinking in response to intravenous ANG II. Although there is no evidence to support this, drinking responses to intravenous ANG II and isoproterenol (see sect. IXA) were greater in rats hypophysectomized 3 wk previously than in normal rats (7). It was suggested that the CVOs (see sect. VIB) become hyperresponsive to circulating ANG II because of upregulation of angiotensin receptors owing to lower levels of ANG II in hypophysectomized rats.
In intact rats, the minimal intravenous infusion rate needed to initiate drinking was ~25 pmol·kg
1·min
1 (273), which would have produced plasma ANG II levels in the region of 200 fmol/ml (Fig. 3) (355). This rate is comparable to the minimum effective rate of infusion of 50 pmol·kg
1·min
1 in two other studies (19, 200). In another experiment on rats, plasma ANG II levels at thirst threshold were found to be ~460 pg/ml, similar to the plasma ANG II levels after ~48 h of water deprivation (634). These values are comparable to those needed to initiate drinking in dogs (see sect. IIIB). However, in one investigation where ANG II was infused intravenously at 10, 30, and 60 ng/min acutely or for 3-day periods, no significant effect on water intake was observed; the highest rate of infusion produced a plasma ANG II of ~1,500 pg/ml at 1 h (439). Furthermore, ANG II did not enhance drinking caused by water deprivation, hypertonic NaCl, or hypotension.
|
The lack of dipsogenic responsiveness to intravenous ANG II that is sometimes encountered could be partly explained by the acute pressor response to ANG II. In an important series of experiments where the effect of the increase in blood pressure on ANG II-induced drinking was investigated, it was found that ANG II infused intravenously by itself at 100 ng/min caused no drinking but did so when the rise in blood pressure was prevented by isoproterenol, diazoxide, or minoxidil; rats were pretreated with captopril to block endogenous formation of ANG II (157, 483, 484). Lower rates of infusion (16.7 and 50 ng/min) on their own caused significant increases in water intake, but the responses were enhanced as much as fivefold when the pressor response was prevented and at the same time urinary fluid losses were reduced. Possible mechanisms for the pressor inhibition of systemic ANG II-induced drinking have been demonstrated in the dog (see sect. IIIB2). There may be other reasons for the relative ineffectiveness of systemic as opposed to intracranial administration of ANG II, such as accessibility of ANG II-sensitive tissue to blood-borne hormone, and there are also important species differences. As will become evident when sodium appetite is considered, there are differences in the drinking behavior produced by systemic and intracranial administration of ANG II, but it is difficult to make direct comparisons between effects produced by hormone reaching accessible tissue in the bloodstream and effects produced by injection of a small volume of peptide in very high concentration into a restricted part of a large sensitive region in the brain, not all of which is necessarily accessible to blood-borne hormone. With intracranial injections in particular, other angiotensinergic functions may be aroused that could modify the ANG II drinking response. Further complications are the side effects, such as the changes in blood pressure or in water and electrolyte excretion produced by the hormone, whether given by the intracranial or systemic route, or by the procedure used to release renal renin, which may interfere with or modify the drinking response. Notwithstanding these problems, there appear to be differences both in the nature and in the apparent sensitivity of the responses to ANG II by the two routes. Intracranial administration causes an immediate and substantial increase in water intake followed by an increase in NaCl intake. The increase in water intake after systemic administration is usually smaller, the phenomenon is less robust, and unless special measures are taken, there appears to be no direct effect of systemic ANG II on sodium appetite in rats.
3. Strain differences
Animals of the same strain, age, body weight, and sex show considerable individual variation in spontaneous water intake and sodium preference. The spontaneous water intake of rats may vary by a factor of more than two on a standard diet, most of the water being taken in association with feeding (196), and observations in humans, dogs, and many other animal species show that there may be huge differences in amounts drunk by different individuals in the same circumstances. These differences do not appear to be secondary to variations in the effectiveness of renal control of the body fluids between individuals, and large drinkers have no difficulty in maintaining fluid balance on smaller intakes. It is also well-established that there may be marked differences in drinking behavior, both spontaneous and in response to dipsogenic and natriorexigenic challenges (effects on sodium appetite are further considered in sect. IVA3), including ANG II, between different strains of laboratory rat. The spontaneous water intake of male Fischer 344 rats was one-half that of age-matched Sprague-Dawley rats, and the water-to-food ratio was ~30% lower (497). After subcutaneous or intravenous ANG II, the water intake of Fischer 344 rats was the same as that of Sprague-Dawley rats, but their response to isoproterenol, a partly angiotensin-dependent stimulus (see sect. IXA), was considerably less, although in a later study (91) water intake and increases in plasma renin after isoproterenol did not apparently differ between strains. Compared with Wistar rats, the Fischer 344 rat has a higher baseline plasma renin activity, increased urinary arginine vasopressin, decreased urine flow, and diminished thirst (408). Hypertensive strains of rat produced by selective breeding for high blood pressure may show differences in both water and NaCl intakes compared with normotensive controls. In a comparison between Dahl inbred Sprague-Dawley rats selected for sensitivity or resistance to the development of hypertension when fed a high-salt diet, both strains drank similar amounts of water after subcutaneous ANG I or II, but the salt-sensitive strain had lower plasma renin activity and drank less after isoproterenol, ACE inhibitors (see sect. IXC) and induction of hypovolemia with polyethylene glycol (see sect. XC) than the salt-resistant strain (500). Rats of another hypertensive strain, the Wistar-Kyoto spontaneously hypertensive strain (SH), showed enhanced baseline preference for NaCl solutions and higher baseline water intakes and higher water to food ratios than the normotensive Wistar-Kyoto controls (WK) (122, 320). In response to subcutaneous ANG II, histamine, or hypertonic NaCl, SH rats were found to drink more water than WK rats. According to one set of findings, the greater intracranial ANG II pressor response of SH rats compared with WK rats was not matched by any differences in intracranial ANG II-induced water intake and vasopressin release (267). However, others have found that intracranial ANG II caused larger water intakes in SH rats than in Sprague-Dawley or WK rats (187, 680). In experiments where SH and WK rats were allowed access to NaCl solutions (0.9, 1.8, and 2.7%) and water, SH rats drank more NaCl and water than WK rats in response to injections of ANG II into the third ventricle and more water than WK rats in response to third ventricular injections of carbachol (187). They also drank significantly more 1.8% NaCl than WK rats in response to systemic captopril (see sect. IXC). On the face of it, the view that mechanisms of thirst and sodium appetite in SH rats are more responsive than in WK rats is supported, but this heightened responsiveness applies to both water and NaCl, and it does not seem to be confined to angiotensin-dependent challenges. The part played by angiotensin peptides formed in the brain in accounting for SH/WK differences is considered in section VII, B and C. But the meaning of differences in drinking behavior between SH and WK rats is uncertain because the differences are as well explained by smaller responses in WK rats as by excessive responses in SH rats. Neither SH nor WK rats can be assumed to be fully inbred and uniform strains. It is probable that many genetic characteristics that are not directly responsible for the increase in blood pressure differ between the substrains depending on their source. For example, within genetic strains of hypertensive rat, high blood pressure can be dissociated from NaCl intake. There is, therefore, considerable biological variation and genetic heterogeneity in SH and WK strains bred in different laboratories, although it is likely that animals selected for hypertension are more homogeneous than the normotensive WK rats with which they are being compared. An illustration of this heterogeneity is the variation in plasma and tissue ACE activity in SH and WK rats from different breeding sources (387). Results in the Brattleboro rat show that marked differences in drinking behavior between strains do not necessarily indicate genetic differences in thirst mechanisms. The Brattleboro rat, derived from a strain of Long-Evans hooded rat, possesses an autosomal recessive trait at a single gene locus which results in a defect in vasopressin synthesis (517). Accordingly, it drinks large quantities of water throughout the day and night to compensate for the greatly increased urinary fluid losses. When allowance is made for the increased water turnover, it appears that the thirst mechanisms are responding normally to the increased need for water (223, 224). What quantitative differences there are seem to fall within the range of what might be expected from using different but normal rat strains. The Brattleboro rat is discussed in section XI.4. Sex differences and sex hormones
An intriguing sex difference is the presence of a renin-like enzyme in much higher concentrations in the salivary glands of male mice than in females. The purification of mouse salivary gland renin was critical in the development of methods for the purification of renal renin (453). The high levels of salivary gland renin in the male fall after castration but can be restored by treating